12 research outputs found

    Aminoglycoside Binding to Oxytricha nova

    No full text

    The HLA-DP2 binding pocket in complex with the crystallized natural peptide of 15 residues.

    No full text
    <p>The 10 residues of the peptide used as a cutting template are shown in red with important residues having extended structure. The removed residues are in yellow. Key residues in HLA-DP2 are shown in green; the aspartic acid is labeled as <i>ASP</i> and the three glutamic acid residues are labeled as <i>GLU Pocket</i>.</p

    Cartoon representation of HLA-DP2 protein (PDB ID 3LQZ).

    No full text
    <p>Peptide binding pocket is shown in light and dark purple. Residues taken into account for distance calculations are in red. Change in RMSD due to peptide/Be binding was analyzed for residues in dark purple. Illustration was made with Chimera software <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0111604#pone.0111604-Pettersen1" target="_blank">[33]</a>.</p

    Graphical depiction of our investigation of the effects of the Be ion on the complex made up of a HLA-DP2 protein, the Be ion, and a small peptide.

    No full text
    <p>We investigated four types of small peptides (“Natural”, “Strong”, “Weak”, and “DR”) and two binding scenarios: (1) the ion bound to a small peptide and (2) the ion bound to the HLA-DP2 protein. Effect predictions include binding affinity, conformation changes of the peptide binding pocket, pKa shifts of titratable groups of the protein upon peptide and/or the Be ion binding.</p

    Illustration of the two investigated binding scenarios.

    No full text
    <p>In the top panel (A) the Be ion is in complex with the protein and then the peptides were added, peptide→(Be+protein) scenario; and in the bottom panel (B) the Be ion is in complex with the peptides and then the protein is added, (Be+peptide)→protein scenario.</p
    corecore